Logo

Lumera Signs Up ISB to Develop Label-Free Protein Array System

Feb 14, 2005

NEW YORK, Feb. 14 (GenomeWeb News) - Lumera will collaborate with the Institute for Systems Biology to develop a label-free protein microarray platform, the Bothell, Wash.-based company said today.

 

The platform will include Lumera's NanoCapture microarrays and its ProteomicProcessor reader, which does not require molecular labels. The new system will enable researchers to perform real-time kinetic measurements of protein-protein, protein-drug, and protein-DNA interactions.

 

Lumera plans to bring the technology to market "as quickly as possible," according to a company statement.

Breaking News
The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.